Start for free
Start for free
KC

Kendall Capital Partners

North America, Massachusetts, United States, Boston

Description

Kendall Capital Partners is an early-stage venture capital firm.

Investor Profile

Kendall Capital Partners has made 6 investments, with 1 in the past 12 months and 33% as lead.

Stage Focus

  • Series Unknown (50%)
  • Series A (33%)
  • Convertible Note (17%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Life Science
  • 3d Technology
  • Artificial Intelligence (Ai)
  • Diabetes
  • Health Diagnostics
  • Medical Device
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kendall Capital Partners frequently co-invest with?

AF
Co-Investments: 1
TM
T&W Medical
Europe, Hovedstaden, Denmark, Lynge
Co-Investments: 1
KdT Ventures
KdT Ventures
North America, Texas, United States, Austin
Co-Investments: 1
AXA Investment Managers
AXA Investment Managers
Europe, Ile-de-France, France, Puteaux
Co-Investments: 1
OP
Other People's Capital (OPC)
North America, New York, United States, New York
Co-Investments: 1
KH
KOFA Healthcare Investments
North America, Indiana, United States, West Lafayette
Co-Investments: 1
Digitalis Ventures
Digitalis Ventures
North America, New York, United States, New York
Co-Investments: 1
Trousdale Ventures
Trousdale Ventures
North America, California, United States, West Hollywood
Co-Investments: 1
THE CATALYTIC IMPACT FOUNDATION (CIF)
THE CATALYTIC IMPACT FOUNDATION (CIF)
North America, New York, United States, New York
Co-Investments: 1
VCapital
VCapital
North America, Illinois, United States, Chicago
Co-Investments: 1

Which angels does Kendall Capital Partners often collaborate with?

KA
Katherine A. High
North America, Pennsylvania, United States, Haverford
Shared Deals: 1

What are some of recent deals done by Kendall Capital Partners?

EpiBone

Jersey City, New Jersey, United States

EpiBone is a bone reconstruction company that advances skeletal reconstruction through 3D design and living cells.

3D TechnologyBiotechnologyHealth CareMedical
Convertible NoteNov 8, 2024
Omnipulse Biosciences

Cambridge, Massachusetts, United States

Omnipulse Biosciences offers single injection quantities suitable for clinical trials and commercial distribution to low-income countries

BiopharmaBiotechnologyHealth Care
Series UnknownDec 21, 2023
Amount Raised: $6,999,999
EpiBone

Jersey City, New Jersey, United States

EpiBone is a bone reconstruction company that advances skeletal reconstruction through 3D design and living cells.

3D TechnologyBiotechnologyHealth CareMedical
Series UnknownDec 27, 2022
Eyenuk

Woodland Hills, California, United States

Eyenuk is a medtech company that develops an artificial intelligence screening tool for risk assessment and disease surveillance.

Artificial Intelligence (AI)DiabetesHealth CareHealth DiagnosticsMedical Device
Series AOct 17, 2022
Amount Raised: $26,000,000
Bilayer Therapeutics

Cambridge, Massachusetts, United States

Bilayer Therapeutics is a biotech company that develops a first-in-class therapeutic for constipation and other diseases of the colon.

BiotechnologyHealth CareLife ScienceTherapeutics
Series UnknownApr 28, 2021
Amount Raised: $2,000,000
Rejuvenate Bio

San Diego, California, United States

Rejuvenate Bio is a biotechnology company that develops therapies to reverse aging and treat age-related diseases.

BiotechnologyHealth CareLife ScienceMedical
Series AApr 12, 2021
Amount Raised: $14,575,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator